Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this


Lino Lazarides will be in attendance at the event. This year, the congress has a Targeted Protein Degradation focus and Linos will be outlining how Charnwood Molecular has successfully employed screening strategies and methodologies for accurately measuring protein degradation.

PROTAC (PROteolysis TArgeting Chimera) is one of the hottest topics in drug discovery today as it is a highly promising new approach to targeted therapy. PROTACs are highly appealing to drug developers as they have the potential to target the ‘undruggable’ proteome.

Charnwood Molecular have extensive expertise in the field of PROTAC. If you want to know more about this, contact Linos at the event or in advance to organise a meeting.

The XIV meeting of the Spanish Drug Discovery Network (SDDN) takes place in Parque Tecnológico de la Salud (PTS) / Universidad de Granada, in Granada, Spain, on November 24 and 25, 2022.

Find out more about our PROTAC expertise here.